Correlatively, our data provide several lines of evidence showing that pharmacological inhibition of CYP2E1 by 4-MP had therapeutic effects on abnormal fetal development and maternal metabolic disorders in ethanol-fed mice. The gene discussed is CYP2E1; the disease is Other metabolic disease.